Neuroproof Systems Gmbh

NeuroProof is a global leader and preferred partner in the field of microelectrode array (MEA)-based phenotypic screening of primary cultures. Neuroproof offers screening services and state-of-the-art artificial intelligence based analytics of functional phenotypic activity pattern of test agents on neuronal network activity. The services comprise the growing of neuronal cell cultures prepared from mouse or derived from human iPSC on MEA chips, medium throughput screening of test agents, high quality recording of spontaneous and compound-induced network activity, state-of-the-art mathematical analyses, and sophisticated pattern recognition methods. The unique platform is well suited to identify and characterize effects of test agents on neuronal network activity and brain cell function. NeuroProof has developed a range of in vitro disease models for neurogenerative and psychological disorders.